Orforglipron
A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
Eli Lilly · Phase 1 · Completed · Enrollment 50
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Cohort 1: Oral Drug Dosing With or Without Orforglipron Co-Administration | n/r | n/r | n/r | n/r | n/r |
| Cohort 2: Oral Drug Dosing With or Without Orforglipron Co-Administration | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.